Home - Excellus Providers

We would like to provide you with information related to the second phase of the New York State Children’s Health and Behavioral Health Medicaid System Transformation, which will occur July 1, 2019.

We would like you to be aware of an upcoming policy update involving the HIV prescription medication, Atripla®. Starting January 1, 2019, step therapy requirements will apply to Atripla®. Additionally, Symfi™ and Symfi Lo™ are the Health Plan’s preferred alternative to Atripla and do not have any restrictions imposed on them.

We would like to share an overview with you regarding our standard medical Utilization Management (UM) Program updates effective for requests beginning July 1, 2019. These updates will be posted to our website, ExcellusBCBS.com, June 3, 2019.